Tumor antigens recognized by T lymphocytes

被引:124
作者
VandenEynde, BJ [1 ]
Boon, T [1 ]
机构
[1] UNIV CATHOLIQUE LOUVAIN,CELLULAR GENET UNIT,B-1200 BRUSSELS,BELGIUM
关键词
cancer; cytolytic T lymphocytes; antigen; peptide; melanoma; renal cell carcinoma; immunotherapy; vaccine;
D O I
10.1007/BF02912440
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In the last five years, knowledge of human tumor antigens recognized by autologous cytolytic T lymphocytes (CTL) has increased considerably. So far, genetic and biochemical approaches have led to the molecular identification of three classes of antigens. Most of these antigens consist of peptides that are presented to T cells by HLA molecules. The first class comprises antigens encoded by genes such as MAGE, BAGE, and GAGE, which are expressed in various tumors of different histological origins, but not in normal tissues other than testis. The second class represents differentiation antigens encoded by genes that are only expressed in melanoma and normal melanocytes like tyrosinase, Melan-A/MART-1, gp100 and gp75. The third class includes antigens produced by unique point mutations in genes that are ubiquitously expressed. In most cases, the antigenic peptide is encoded by the mutated region of the gene. A number of these antigens provide promising targets for new protocols of specific cancer immunotherapy.
引用
收藏
页码:81 / 86
页数:6
相关论文
共 56 条
[1]   MELANOMA-CELLS AND NORMAL MELANOCYTES SHARE ANTIGENS RECOGNIZED BY HLA-A2-RESTRICTED CYTOTOXIC T-CELL CLONES FROM MELANOMA PATIENTS [J].
ANICHINI, A ;
MACCALLI, C ;
MORTARINI, R ;
SALVI, S ;
MAZZOCCHI, A ;
SQUARCINA, P ;
HERLYN, M ;
PARMIANI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :989-998
[2]   CLONAL ANALYSIS OF THE CYTOLYTIC T-CELL RESPONSE TO HUMAN-TUMORS [J].
ANICHINI, A ;
FOSSATI, G ;
PARMIANI, G .
IMMUNOLOGY TODAY, 1987, 8 (12) :385-389
[3]   MELANOCYTE LINEAGE-SPECIFIC ANTIGEN GP100 IS RECOGNIZED BY MELANOMA-DERIVED TUMOR-INFILTRATING LYMPHOCYTES [J].
BAKKER, ABH ;
SCHREURS, MWJ ;
DEBOER, AJ ;
KAWAKAMI, Y ;
ROSENBERG, SA ;
ADEMA, GJ ;
FIGDOR, CG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :1005-1009
[4]   BAGE - A NEW GENE ENCODING AN ANTIGEN RECOGNIZED ON HUMAN MELANOMAS BY CYTOLYTIC T-LYMPHOCYTES [J].
BOEL, P ;
WILDMANN, C ;
SENSI, ML ;
BRASSEUR, R ;
RENAULD, JC ;
COULIE, P ;
BOON, T ;
VANDERBRUGGEN, P .
IMMUNITY, 1995, 2 (02) :167-175
[5]   TOWARD A GENETIC-ANALYSIS OF TUMOR REJECTION ANTIGENS [J].
BOON, T .
ADVANCES IN CANCER RESEARCH, 1992, 58 :177-210
[6]   A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma [J].
Brandle, D ;
Brasseur, F ;
Weynants, P ;
Boon, T ;
VandenEynde, BJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2501-2508
[7]   EXPRESSION OF MAGE GENES IN PRIMARY AND METASTATIC CUTANEOUS MELANOMA [J].
BRASSEUR, F ;
RIMOLDI, D ;
LIENARD, D ;
LETHE, B ;
CARREL, S ;
ARIENTI, F ;
SUTER, L ;
VANWIJCK, R ;
BOURLOND, A ;
HUMBLET, Y ;
VACCA, A ;
CONESE, M ;
LAHAYE, T ;
DEGIOVANNI, G ;
DERAEMAECKER, R ;
BEAUDUIN, M ;
SASTRE, X ;
SALAMON, E ;
DRENO, B ;
JAGER, E ;
KNUTH, A ;
CHEVREAU, C ;
SUCIU, S ;
LACHAPELLE, JM ;
POUILLART, P ;
PARMIANI, G ;
LEJEUNE, F ;
CEROTTINI, JC ;
BOON, T ;
MARCHAND, M .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (03) :375-380
[8]   HUMAN GENE MAGE-1, WHICH CODES FOR A TUMOR-REJECTION ANTIGEN, IS EXPRESSED BY SOME BREAST-TUMORS [J].
BRASSEUR, F ;
MARCHAND, M ;
VANWIJCK, R ;
HERIN, M ;
LETHE, B ;
CHOMEZ, P ;
BOON, T .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (05) :839-841
[9]   THE TYROSINASE GENE CODES FOR AN ANTIGEN RECOGNIZED BY AUTOLOGOUS CYTOLYTIC T-LYMPHOCYTES ON HLA-A2 MELANOMAS [J].
BRICHARD, V ;
VANPEL, A ;
WOLFEL, T ;
WOLFEL, C ;
DEPLAEN, E ;
LETHE, B ;
COULIE, P ;
BOON, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :489-495
[10]   A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes [J].
Brichard, VG ;
Herman, J ;
VanPel, A ;
Wildmann, C ;
Gaugler, B ;
Wolfel, T ;
Boon, T ;
Lethe, B .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (01) :224-230